Anti-inflammatory drugs

(redirected from Non-steroidal anti-inflammatory drug)
Also found in: Dictionary, Thesaurus, Acronyms, Encyclopedia, Wikipedia.

Anti-inflammatory drugs

A class of drugs that lower inflammation and that includes NSAIDs and corticosteroids.
Mentioned in: Antirheumatic Drugs
Gale Encyclopedia of Medicine. Copyright 2008 The Gale Group, Inc. All rights reserved.
References in periodicals archive ?
PENNSAID (diclofenac sodium topical solution) 2% w/w is a non-steroidal anti-inflammatory drug (NSAID) indicated for the treatment of pain of osteoarthritis (OA) of the knee(s).
To avoid irritation and other side effects, some people have switched to a non-steroidal anti-inflammatory drug (NSAID) like naproxen.
Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) that possesses three therapeutic properties; anti-inflammatory, analgesic and antipyretic action.
The product two percent w/w is a non-steroidal anti-inflammatory drug indicated for the treatment of pain of osteoarthritis for the knee.
According to the company, PENNSAID (diclofenac sodium topical solution) 2% w/w is a non-steroidal anti-inflammatory drug (NSAID) indicated for the treatment of pain of osteoarthritis (OA) of the knee(s).
M2 EQUITYBITES-April 20, 2015-Horizon Pharma receives the US Patent and Trademark Office's additional notice of allowance for non-steroidal anti-inflammatory drug PENNSAID 2%
The company added PENNSAID 2% (diclofenac sodium topical solution) is a topical non-steroidal anti-inflammatory drug (NSAID) approved for use in the treatment of the pain of osteoarthritis of the knee(s).
According to the company, BromSite combines a low dose (0.075%) of the non-steroidal anti-inflammatory drug (NSAID) bromfenac with its DuraSite drug delivery technology.
Iroko Pharmaceuticals, a speciality pharmaceutical company, has received approval from FDA for new Drug Application filing of lower dose submicron Indomethacin, a non-steroidal anti-inflammatory drug, it was reported yesterday.
VIMOVO is a fixed-dose combination of delayed-release enteric-coated naproxen, a non-steroidal anti-inflammatory drug (NSAID), and immediate-release esomeprazole, a stomach acid-reducing proton pump inhibitor (PPI).
The company said that BromSite (ISV-303) combines a low dose (0.075%) of the non-steroidal anti-inflammatory drug (NSAID) bromfenac with its DuraSite drug delivery technology.

Full browser ?